Literature DB >> 33575459

Anaesthesia considerations and techniques for Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC).

Venkatesan Shree1,2, Tian Jin Lim1,2, Lyn Li Lean1,2, Bok Yan Jimmy So3,4, Guowei Kim3,4.   

Abstract

Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC) is a novel surgical technique to administer aerosolized chemotherapy into the abdominal cavity as treatment for peritoneal metastasis from various cancers. As the surgery is unique and there are concerns about occupational hazards, specific anaesthetic setup and techniques are required. Notably, our institution's experience with PIPAC has enlightened us that anaesthesia requirements during PIPAC are generally uncomplicated and that the majority of the patients undergoing PIPAC do not require invasive monitoring, advanced intra or postoperative analgesia like epidurals or PCA. The need for postoperative intensive unit care is also not required in routine PIPAC cases. We describe the anaesthetic considerations involved and the detailed preparation of staff, space, anaesthetic equipment and drugs to facilitate the appropriate modifications for anaesthesia monitoring and maintenance for an elective set up as well as our standard operating procedure for an emergency situation should it arise.
© 2020 Venkatesan Shree et al., published by De Gruyter, Berlin/Boston.

Entities:  

Keywords:  Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC) anaesthesia considerations; anaesthesia setup; total intravenous anaesthesia (TIVA)

Year:  2020        PMID: 33575459      PMCID: PMC7823152          DOI: 10.1515/pp-2019-0013

Source DB:  PubMed          Journal:  Pleura Peritoneum        ISSN: 2364-768X


  6 in total

Review 1.  Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis.

Authors:  F Grass; A Vuagniaux; H Teixeira-Farinha; K Lehmann; N Demartines; M Hübner
Journal:  Br J Surg       Date:  2017-05       Impact factor: 6.939

2.  Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report.

Authors:  Matthieu Siebert; Mohammad Alyami; Frederic Mercier; Colin Gallice; Laurent Villeneuve; Frédéric Bérard; Olivier Glehen; Naoual Bakrin; Vahan Kepenekian
Journal:  Cancer Chemother Pharmacol       Date:  2018-12-03       Impact factor: 3.333

Review 3.  Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure.

Authors:  R L Dedrick; M F Flessner
Journal:  J Natl Cancer Inst       Date:  1997-04-02       Impact factor: 13.506

Review 4.  Intraperitoneal antineoplastic drug delivery: rationale and results.

Authors:  Maurie Markman
Journal:  Lancet Oncol       Date:  2003-05       Impact factor: 41.316

Review 5.  Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy.

Authors:  Martin D Goodman; Sarah McPartland; Danielle Detelich; Muhammad Wasif Saif
Journal:  J Gastrointest Oncol       Date:  2016-02

6.  Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy.

Authors:  Wiebke Solass; Reinhold Kerb; Thomas Mürdter; Urs Giger-Pabst; Dirk Strumberg; Clemens Tempfer; Jürgen Zieren; Matthias Schwab; Marc André Reymond
Journal:  Ann Surg Oncol       Date:  2013-09-05       Impact factor: 5.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.